New hope for lung cancer: immunotherapy drug tested in untreated patients
NCT ID NCT05047250
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests a drug called atezolizumab in 60 people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. Participants have not had chemotherapy before. The goal is to see if the drug helps them live longer and controls the cancer. This is a phase 3 trial, meaning it is in the final stage of testing before possible approval.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Province Cancer Hospital
Hefei, 230001, China
-
Beijing Chest Hospital
Beijing, 101149, China
-
Beijing Tiantan Hospital,Capital Medical University
Beijing, 100050, China
-
Cancer Hospital of Shantou University Medical College
Shantou, 515041, China
-
Daping Hospital of Third Military Medical University
Chongqing, 400042, China
-
Fujian Cancer Hospital
Fuzhou, 350014, China
-
Linyishi Cancer Hospital
Linyi, 276034, China
-
Nanjing Chest Hospital
Nanjing, 210029, China
-
Renmin Hospital of Wuhan University
Wuhan, 430060, China
-
Shanghai Chest Hospital
Shanghai, 200000, China
-
Sir Run Run Shaw Hospital Zhejiang University
Hangzhou, 310016, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, 230022, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, 361003, China
-
The Third Xiangya Hospital Of Central South University
Changsha, 410013, China
-
Tianjin Cancer Hospital
Tianjin, 300060, China
-
Tianjin Medical University General Hospital
Tianjin, 300052, China
-
Tumor Center,Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, 430023, China
-
Xuanwu Hospital, Capital Medical University
Beijing, 100053, China
Conditions
Explore the condition pages connected to this study.